Teva gets approval on generic Aciphex |
|
|
|
Published
:
Thu, 22 Feb 2007 17:16
|
NEW YORK (AP) - Generic drug developer Teva Pharmaceutical Industries Ltd. said Thursday the Food and Drug Administration approved its generic version of Eisai Co.'s heartburn drug Aciphex.Israel-based Teva is involved in a patent lawsuit with Eisai over the delayed-release, 20-milligram tablets. A trial in the U.S. District Court for the Southern District of New York is scheduled for March 5.Shares of Teva fell 43 cents to $37.92 on the Nasdaq Stock Market in morning trading.Copyright 2006 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Teva suing over generic Zoloft patents 